mephentermine has been researched along with Shock, Cardiogenic in 12 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BESTERMAN, EM | 1 |
KELLER, ML | 1 |
AGRESS, CM | 1 |
Wenger, R | 1 |
Ahlquist, RP | 1 |
Moran, NC | 1 |
Abou-Madi, MN | 1 |
Yacoub, JM | 1 |
Camillo, OS | 1 |
Pema, PJ | 1 |
Döring, D | 1 |
Lieschke, HJ | 1 |
Mills, LC | 1 |
Moyer, JH | 1 |
2 reviews available for mephentermine and Shock, Cardiogenic
Article | Year |
---|---|
THERAPY OF CARDIOGENIC SHOCK.
Topics: Angiotensins; Cardiac Tamponade; Heart Aneurysm; Heart Diseases; Heart Failure; Humans; Hydromorphon | 1963 |
Management of shock in acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Cardiac Output; Central Venous Pressure; Dextrans; Digitalis Glycosides; Do | 1971 |
10 other studies available for mephentermine and Shock, Cardiogenic
Article | Year |
---|---|
Treatment of cardiac shock by metaraminol.
Topics: Humans; Mephentermine; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Shock, Cardiogenic | 1959 |
Vasopressor drugs in the treatment of cardiogenic shock.
Topics: Humans; Hypertension; Mephentermine; Metaraminol; Methamphetamine; Myocardial Infarction; Norepineph | 1963 |
[Drug therapy in cardiogenic shock].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Chlorpromazine; Digitalis Glycosides; Dopamin | 1973 |
Pharmacology of pressor agents on the systemic circulation.
Topics: Action Potentials; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Epinephrine; Humans; | 1973 |
Evaluation of the pharmacologic basis for the therapy of circulatory shock.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Blood Vessels; Digitalis | 1970 |
An unusual complication of fiberoptic esophagoscopy.
Topics: Aged; Carcinoma; Esophageal Neoplasms; Esophagoscopy; Fiber Optic Technology; Humans; Injections, In | 1974 |
[Clinics and therapy of schock in myocardial infarct].
Topics: Digitalis Glycosides; Electrocardiography; Epinephrine; Heart Arrest; Humans; Isoproterenol; Mephent | 1969 |
[Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock].
Topics: Blood Circulation; Blood Pressure; Dopamine; Humans; Mephentermine; Shock, Cardiogenic; Sympathomime | 1971 |
[Influencing of the kidney function by new sympathomimetics].
Topics: Adolescent; Adult; Aminohippuric Acids; Dopamine; Female; Humans; Insulin; Kidney; Kidney Function T | 1971 |
Indications for adrenergic stimulators in shock.
Topics: Blood Pressure; Blood Volume; Cardiac Output; Carotid Arteries; Central Venous Pressure; Cerebrovasc | 1971 |